SARS-CoV-2-IN-21
SARS-CoV-2-IN-21 (compound 10), a penicillin sulfone benzyl C6 derivative, is a potent SARS-CoV-2 main protease inhibitor, with an IC50 of 5.3 μM. SARS-CoV-2-IN-21 can be used for COVID-19 research[1].
Product Specifications
CAS Number
89971-88-0
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-21.html
Solubility
10 mM in DMSO
Smiles
O=C1[C@H]([C@@H]2N1[C@H](C(C)(S2(=O)=O)C)C(OCC3=CC=CC=C3)=O)NC(COC4=CC=CC=C4)=O
Molecular Formula
C23H24N2O7S
Molecular Weight
472.51
References & Citations
[1]Malla TR, et al. Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine. J Med Chem. 2022 May 12:acs.jmedchem.1c02214.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041762-500 1x 500 µL
Bcl-X (Apoptosis Marker) (BCL2L1/1762), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSR030539 100 µg
Recombinant HCoV-OC43 S1+S2 Protein (ECD, His Tag)
Sign In for Pricing
View Details 